Tirzepatide 99.8% Purity — Shandong Aishi BiotechnologyCertificate of Analysis · Independent third-party lab result
LabE tested this tirzepatide batch (11Sept25-SS-63) at 99.78% purity via HPLC. The tested quantity of 46.2mg showed a notable deviation of -7.6% from the 50mg label. Endotoxin status is not applicable, and the test is recent (under 3 months). Customers can cross-check on the lab's public verification URL.
- quantity deviation (-7.6%)
- no endotoxin test
- Test date
- 2026-02-20
- Testing lab
- LabE
- Batch / lot
- 11Sept25-SS-63
- Quantity
- 46.2mg
- Endotoxins
- —
- Assay method
- HPLC + mass quantification + endotoxins
- Test score
- 8.8
- Label dose
- 50mg
How this result compares
This Tirzepatide certificate's tested purity of 99.78% ranks higher than 38% of the 7378 Tirzepatide certificates with a purity result we have catalogued (median 99.82%).
Tested 2026-02-20 by LabE via HPLC + mass quantification + endotoxins. This test is newer than 66% of our catalogued Tirzepatide certificates.
Shandong Aishi Biotechnology has 74 certificates in our corpus, including 28 for Tirzepatide at a median tested purity of 99.89%.
Test report image
Finnrick
Artifact capturedWe have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact shown here.
Verify on the upstream labSaved source document
sha256:6d01f7a4478d45de…
— immutable copy held by TitrateLab